ReviewDementia & neuropsychologia
Individual integrity and public morality in scientific publishing.
Review in Dementia & neuropsychologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Science and science reporting are under threat. Knowingly or not, researchers and clinicians are part of this debacle. This is not due so much to the notorious replication crisis, as to our acceptance of lowering common morality for personal gains, including the widespread, deprecable phenomenon of predatory publishing. Rather than fiercefully countering this loathsome practice, academics are accepting, often supporting a masquerade solution: paying several thousand dollars to publish for all their own papers. This new policy will create a disparity across richer and poorer disciplines; will result in concentrating even more in the hands of large, rich, Western institutions, also penalising younger researchers; will kill observational studies and exploratory research; and will make disseminating science depending more on finances than on quality. This article calls for the full awareness of the academic community on the risks of the current situation in scientific publishing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.